COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,032 Articles (22,627 medRxiv, 8,405 bioRxiv)

Most recent first Previous |  Page 57: Articles 561-570  | Next

Exploring Diverse Binding Mechanisms of Broadly Neutralizing Antibodies S309, S304, CYFN-1006 and VIR-7229 Targeting SARS-CoV-2 Spike Omicron Variants: Integrative Computational Modeling Reveals Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape
Alshahrani, M., Parikh, V., Foley, B., Verkhivker, G.
10.1101/2025.04.15.649027 — Posted: 2025-04-17
Long-lasting impact of the COVID-19 pandemic on incidence and mortality of patients hospitalized for acute heart failure: a nationwide cohort study of the entire French population from 2013 to 2023
Moulaire, P., Delory, T., Oghina, S., Damy, T., Espagnacq, M., Khlat, M., Le Coeur, S., Hejblum, G., Lapidus, N.
10.1101/2025.04.14.25325820 — Posted: 2025-04-16
Retrospective evaluation of school-related measures on pre-vaccination transmission dynamics of SARS-CoV-2
Canfora, B., Escosio, R. A., van Dorp, C. H., Boldea, O., Bonten, M., Nunes, A., Rozhnova, G.
10.1101/2025.04.14.25325720 — Posted: 2025-04-16
Contributions of Genetic Liability and the COVID-19 Pandemic to Rising Psychopathology Among Youth in the United States
Shao, L., Ahern, J., Loughnan, R., Xu, B., Baker, H. E., Tapert, S. F., Baker, F. C., Thompson, W. K., Kiss, O., Muller-Oehring, E. M., Gombert-Labedens, M., Fan, C. C.
10.1101/2025.04.14.25325727 — Posted: 2025-04-16
COVID-19 Pandemic-related differences in the prevalence of genetic conditions and healthcare utilization and access for children with genetic conditions the United States.
Thakral, A., Moorthy, D., Tandon, T., Viswanathan, K., Kupferman, F.
10.1101/2025.04.14.25325831 — Posted: 2025-04-16
Mapping Structural Barriers: A Geospatial Assessment of COVID-19 Vaccine Inequities in Kenya
Nino, L., Kiragga, A., Miller, F. D., Mwalili, S., Musuka, G., Cuadros, D. F.
10.1101/2025.04.14.25325797 — Posted: 2025-04-16
Estimating the effectiveness of non-pharmaceutical interventions against COVID-19 transmission in the Netherlands
Backer, J. A., Klinkenberg, D., Miura, F., Wallinga, J.
10.1101/2025.04.14.25325804 — Posted: 2025-04-16
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic Setting
Samandari, T., Achola, M., Hutter, J. N., Mboya, G., Otieno, W., Kee, J. J., Huang, Y., Aponte, J. J., Ockenhouse, C. F., Lee, C. K., Polakowski, L. L. K., Yacovone, M., Tapley, A., Dadabhai, S., Mkhize, N. N., Kaldine, H., Bhebhe, S., Moore, P., Hural, J., Garrett, N., Kublin, J.
10.1101/2025.04.12.25325718 — Posted: 2025-04-16
COVID-19 and Influenza vaccine co-administration, and missed opportunities to increase COVID-19 vaccination coverage among U.S. adults, 2023-2024
Qasmieh, S. A., Penrose, K., Robertson, M. M., Piltch-Loeb, R., Rane, M. S., Nash, D.
10.1101/2025.04.14.25325480 — Posted: 2025-04-16
STUDY OF FACTORS ASSOCIATED WITH PSYCHOSOCIAL WELL-BEING DURING THE COVID-19 PANDEMIC IN SENEGAL
KASSE, F., Tine, J. A., Faye, A., Gaye, I., Diallo, A. I., Ridde, V.
10.1101/2025.04.15.25325869 — Posted: 2025-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).